nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new resistance mechanism to cisplatin?
|
Kelland, Lloyd R. |
|
2000 |
3 |
3 |
p. 139-141 3 p. |
artikel |
2 |
Book Review: AIDS Therapy
|
Mertz, Gregory J. |
|
2000 |
3 |
3 |
p. 191- 1 p. |
artikel |
3 |
Cancer research 2000: drug resistance, new targets and drugs in development
|
Broxterman, Henk J. |
|
2000 |
3 |
3 |
p. 133-138 6 p. |
artikel |
4 |
Clinical applications of telomerase in cancer treatment
|
Faraoni, Isabella |
|
2000 |
3 |
3 |
p. 161-170 10 p. |
artikel |
5 |
In vivo veritas: Bcl-2 and Bcl-XLmediate tumor cell resistance to chemotherapy
|
Fujita, Naoya |
|
2000 |
3 |
3 |
p. 149-154 6 p. |
artikel |
6 |
β -Lactamases: which ones are clinically important?
|
Rice, Louis B |
|
2000 |
3 |
3 |
p. 178-189 12 p. |
artikel |
7 |
Liposomal formulations of anticancer drugs: selectivity and effectiveness
|
Massing, Ulrich |
|
2000 |
3 |
3 |
p. 171-177 7 p. |
artikel |
8 |
MEETINGS CALENDAR
|
|
|
2000 |
3 |
3 |
p. 193-196 4 p. |
artikel |
9 |
Sulfonamide resistance: mechanisms and trends
|
Sköld, Ola |
|
2000 |
3 |
3 |
p. 155-160 6 p. |
artikel |
10 |
The role of reductive enzymes in cancer cell resistance to mitomycin C
|
Cummings, Jeffrey |
|
2000 |
3 |
3 |
p. 143-148 6 p. |
artikel |